EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

N6‐methyladenosine‐modified circTEAD1 stabilizes Yap1 mRNA to promote chordoma tumorigenesis

Hanwen Li, Yingchuang Tang, Xingbang Ruan, Junxin Zhang, Hao Liu, Shiyu Yu, Hao Chen, Huilin Yang, Kai Zhang, Kangwu Chen iD

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.1658 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Hanwen Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China. Hauptthemen laut MEDLINE: Adenosine, RNA, Circular, YAP-Signaling Proteins, Chordoma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Nature Science Foundation of China, Natural Science Foundation of Jiangsu Province, Suzhou Gusu Health Talent Plan talent research project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chordoma, a rare bone tumour with aggressive local invasion and high recurrence rate with limited understanding of its molecular mechanisms. Circular RNAs (circRNAs) have been extensively implicated in tumorigenesis, yet their involvement in chordoma remains largely unexplored. N6‐methyladenosine (m6A) modification holds a crucial function in regulating protein translation, RNA degradation and transcription.

Methods

Initially, screening and validation of circTEAD1 in chordoma were conducted by high‐throughput sequencing. Subsequently, sh‐circTEAD1 and an overexpression plasmid were constructed. Colony formation assays, cell counting kit‐8, Transwell and wound healing assays were utilized to validate the function of circTEAD1 in vitro. RNA pull‐down assays identified the binding proteins of circTEAD1, which underwent verification through RNA immunoprecipitation (RIP). Methylated RIP assays were conducted to detect the m6A binding sites. Following this, luciferase assay, RT‐qPCR, RIP and Western blotting analyses were conducted, revealing that Yap1 was the direct target of circTEAD1. Afterwards, the same methods were utilized for the validation of the function of Yap1 in chordoma in vitro. Finally, the regulatory relationship between circTEAD1 and Yap1 in chordoma was verified by an in vivo tumour formation assay.

Results

CircTEAD1 was identified as an upregulated circRNA in chordoma specimens, with heightened circTEAD1 expression emerging as a prognostic indicator. In vitro experiments convincingly demonstrated that circTEAD1 significantly promoted chordoma cell invasion, migration and aggressiveness. Furthermore, the analysis revealed that methyltransferase‐like 3‐mediated m6A modification facilitated the cytoplasmic export of circTEAD1. The circTEAD1/IGF2BP3/Yap1 mRNA RNA‐protein ternary complex not only bolstered the stability of Yap1 mRNA but also exerted a pivotal role in driving chordoma tumorigenesis.

Conclusions

In this study, the role of m6A‐modified circTEAD1 in chordoma was identified. The findings offer novel insights into the potential molecular targets for chordoma therapy, shedding light on the intricate interplay between circRNAs, m6A modification and Yap1 mRNA in chordoma pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineRNA, CircularYAP-Signaling ProteinsChordomaTranscription FactorsHumansCarcinogenesisRNA, MessengerAdaptor Proteins, Signal TransducingAnimalsMiceCell Line, Tumor

Stichwörter der Autor:innen

ChordomaCircRNAsHippo pathwayN6‐methyladenosine modification

Substanzen

AdenosineRNA, CircularN-methyladenosineYAP1 protein, humanYAP-Signaling ProteinsTranscription FactorsRNA, MessengerAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Department of Orthopedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.
  • Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, People's Republic of China.

ORCID-Profile: Kangwu Chen

Förderung

  • National Nature Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Suzhou Gusu Health Talent Plan talent research project
  • Natural Science Foundation for Training Program of the First Affiliated Hospital of Soochow University
  • National Natural Science Foundation of China

Zitieren

APA

Li, H., Tang, Y., Ruan, X., Zhang, J., Liu, H., Yu, S., Chen, H., Yang, H., Zhang, K., & Chen, K. (2024). N6‐methyladenosine‐modified circTEAD1 stabilizes Yap1 mRNA to promote chordoma tumorigenesis. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1658

Vancouver

Li H, Tang Y, Ruan X, Zhang J, Liu H, Yu S, et al. N6‐methyladenosine‐modified circTEAD1 stabilizes Yap1 mRNA to promote chordoma tumorigenesis. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1658

BibTeX
@article{Li2024,
  author = {Li, Hanwen and Tang, Yingchuang and Ruan, Xingbang and Zhang, Junxin and Liu, Hao and Yu, Shiyu and Chen, Hao and Yang, Huilin and Zhang, Kai and Chen, Kangwu},
  title = {N6‐methyladenosine‐modified circTEAD1 stabilizes Yap1 mRNA to promote chordoma tumorigenesis},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.1658}
}
Kostenlos starten →